Registry and Repository Boot Camp Agenda & Materials

Registry and Repository Boot Camp Agenda & Materials

Biobank Logo

Registry and Repository Boot Camp
Doubletree Hotel, Bethesda, MD
January 10, 2010
Faculty: Sharon Terry, MA, President and CEO, Genetic Alliance
Liz Horn, PhD, MBI, Director, Genetic Alliance BioBank

Agenda
Download [PDF]

3:00 PM Introductions
In this session, we welcome participants and preview the training sessions that will follow. Participants will be asked to introduce themselves and describe their interest in registries and repositories: something they know and something they would like to learn.
3:30 PM The need for data collection to accelerate rare disease research
This session provides a general overview of registries and repositories in the context of GRANDRx, results from a recent landscape analysis of registries and repositories conducted by Genetic Alliance, and examples of successful registry and repository models.

Successful Models:

  • Leslie Gordon, MD, PhD, Progeria Research Foundation
  • Sharon Terry, MA, PXE International
4:15 PM Concurrent sessions
This session provides a comprehensive review of practical things to consider when creating a registry and/or repository. Areas of focus include determining what data or samples to collect, processes and infrastructure for collecting data or samples, organizational structures for collection, and governance.

  • Track 2 - Utilizing the power of registries/repositories to meet the research agenda
What is your ultimate research goal (s)? Do you know where you are on the 'map' and can you navigate the steps of the project plan vis-à-vis your registry and repository?
5:00 PM Concurrent sessions
This session reviews key considerations for assessing registry and/or repository vendors. Areas of focus include registry capacity, repository capacity, scalability, quality of information, and ability to adapt to future legal standards.

  • Track 2 - Fine-tuning your registry/repository for success
Once your registry and/or repository resource is established, it is important to continue to evaluate its capacity and position in the community. This session enables participants to perform a SWOT analysis (strengths, weaknesses, opportunities, and threats) to evaluate and fine-tune their resource.
5:45 PM Concurrent sessions
This session will take what participants have learned from the start-up guide and vendor assessment to help determine the capacity of their organization to develop a registry and/or repository. An assessment tool will provide insight on areas of strength and those that could be improved.

  • Track 2 - Legal issues: governance, ownership, IRBs, and informed consent
This session provides practical information on complex legal issues surrounding registries and repositories. Areas of focus include governance, ownership, privacy, IRBs, and the process of
informed consent.
6:30 PM Dinner (open networking)
7:00 PM Access for participants: Private Access
Robert Shelton, CEO, Private Access, Chairman, KS&A
In this session we will showcase some remarkable technology that will provide web 2.0 technology to establish “private access”. Donors are able to make their information available to trusted researchers or research groups and decide who should have the ability to search and view this information on the basis of anonymous or personally-identifiable records.
7:30 PM Building collaboration
Jungdae Kokotov, Project Manager, 5 AM Solutions
Collaboration is key in research. This session will highlight strategies to improve collaboration between diverse stakeholders and provide examples of
successful collaborations.
8:00 PM Development strategies: A good idea never lacks for funding
Lisa Wise, COO, Genetic Alliance
Adequate funding and resource management are vital for registries and repositories. This session will review fundraising strategies to build and sustain your registry or repository.
8:30 PM Open Q&A
9:00 PM Adjourn

Sponsored by the Office of Rare Disease Research and Genetic Alliance

Combined Federal Campaign (CFC)
#80146
4301 Connecticut Avenue NW - Suite 404
Washington, DC 20008-2369
Tel: 202.966.5557 Fax: 202.966.8553
info@geneticalliance.org